Alcidion (ASX:ALC)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alcidion.
RELATED STOCKHEAD STORIES
Rise and Shine: Everything you need to know before the ASX opens
Health Check: In rude health, Alcidion shrugs off UK National Health Service reforms
Closing Bell: WiseTech crumbles 20pc, but APA saves the day with big gas plans
Lunch Wrap: Domain soars 40pc on CoStar bid; GYG tumbles despite solid half
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Digital prescription: ASX stocks transforming healthcare sector
Dr Boreham’s Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
ASX Small Caps Lunch Wrap: We’re not living in a Materials world anymore. At least not today
ASX Health Stocks: Alcidion soars as it helps bring UK patient records into digital age
ASX Health Stocks: Immutep gets crucial therapy trial clearance; Alcidion wins $4m deal
Market Highlights: Records tumble, Powell to testify, and 5 ASX small caps to watch today
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
